Cita APA (7a ed.)
LEVITAN, D. (2018). TLR9 agonist may improve melanoma Tx response. Dermatology Times, 39(10), 59-60.
Cita Chicago Style (17a ed.)
LEVITAN, DAVE. "TLR9 Agonist May Improve Melanoma Tx Response." Dermatology Times 39, no. 10 (2018): 59-60.
Cita MLA (9a ed.)
LEVITAN, DAVE. "TLR9 Agonist May Improve Melanoma Tx Response." Dermatology Times, vol. 39, no. 10, 2018, pp. 59-60.
Precaución: Estas citas no son 100% exactas.